Page last updated: 2024-08-18

isomethyleugenol and panobinostat

isomethyleugenol has been researched along with panobinostat in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Choi, YL; Hasegawa, H; Hayashi, T; Imaizumi, Y; Kamihira, S; Mano, H; Marquez, VE; Miyazaki, Y; Moriwaki, Y; Osaka, A; Sasaki, D; Tsukasaki, K; Yamada, Y; Yanagihara, K	1
Ehteda, A; Franshaw, L; Giorgi, FM; Gopalakrishnan, A; Gudkov, AV; Gurova, K; Haber, M; Hayden, E; Joshi, S; Kankean, A; Khan, A; Lehmann, R; Liu, J; Mayoh, C; Norris, MD; Pandher, R; Pang, CNI; Rouaen, JRC; Shen, S; Simon, S; Tang, Y; Tolhurst, O; Trebilcock, P; Tsoli, M; Ung, C; Vittorio, O; Ziegler, DS	1

Other Studies

2 other study(ies) available for isomethyleugenol and panobinostat

Article	Year
Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy. Haematologica, 2011, Volume: 96, Issue:5 Topics: Adenosine; Base Sequence; Blotting, Western; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Epigenomics; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Histones; Humans; Hydroxamic Acids; Indoles; Intracellular Signaling Peptides and Proteins; Leukemia-Lymphoma, Adult T-Cell; Lysine; Methylation; MicroRNAs; Oligonucleotide Array Sequence Analysis; Panobinostat; Polycomb Repressive Complex 1; Polycomb Repressive Complex 2; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors	2011
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG. Cell reports, 2021, 04-13, Volume: 35, Issue:2 Topics: Acetylation; Animals; Antineoplastic Agents; Brain Stem Neoplasms; Carbazoles; Cell Cycle Proteins; Cell Line, Tumor; Child; Chromatin; Diffuse Intrinsic Pontine Glioma; DNA-Binding Proteins; Drug Synergism; E2F1 Transcription Factor; Epigenesis, Genetic; Epigenome; High Mobility Group Proteins; Histones; Humans; Methylation; Mice; Neuroglia; Panobinostat; Primary Cell Culture; Retinoblastoma Protein; Signal Transduction; Survival Analysis; Transcription Factors; Transcriptional Elongation Factors; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2021

Article

Year

Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy.

Haematologica, 2011, Volume: 96, Issue:5

Topics: Adenosine; Base Sequence; Blotting, Western; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Epigenomics; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Histones; Humans; Hydroxamic Acids; Indoles; Intracellular Signaling Peptides and Proteins; Leukemia-Lymphoma, Adult T-Cell; Lysine; Methylation; MicroRNAs; Oligonucleotide Array Sequence Analysis; Panobinostat; Polycomb Repressive Complex 1; Polycomb Repressive Complex 2; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors

2011

Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG.

Cell reports, 2021, 04-13, Volume: 35, Issue:2

Topics: Acetylation; Animals; Antineoplastic Agents; Brain Stem Neoplasms; Carbazoles; Cell Cycle Proteins; Cell Line, Tumor; Child; Chromatin; Diffuse Intrinsic Pontine Glioma; DNA-Binding Proteins; Drug Synergism; E2F1 Transcription Factor; Epigenesis, Genetic; Epigenome; High Mobility Group Proteins; Histones; Humans; Methylation; Mice; Neuroglia; Panobinostat; Primary Cell Culture; Retinoblastoma Protein; Signal Transduction; Survival Analysis; Transcription Factors; Transcriptional Elongation Factors; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2021